Pharma Reviews: Indian pharma no longer a growth tonic for FIIs
MUMBAI: Saddled with heightened USFDA scrutiny, a strong rupee, weak commercial potential of drugs in the pipeline, the Indian pharmaceutical ...
Read more: Indian pharma no longer a growth tonic for FIIs